Rockefeller Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Buy |
38,766
+21,531
| +125% | +$930K | ﹤0.01% | 1170 |
|
|
2025
Q1 | $596K | Sell |
17,235
-24,054
| -58% | -$832K | ﹤0.01% | 1431 |
|
|
2024
Q4 | $1.13M | Buy |
41,289
+30
| +0.1% | +$823 | ﹤0.01% | 1202 |
|
|
2024
Q3 | $1.05M | Buy |
41,259
+4,317
| +12% | +$110K | ﹤0.01% | 1211 |
|
|
2024
Q2 | $936K | Sell |
36,942
-4,070
| -10% | -$103K | ﹤0.01% | 1228 |
|
|
2024
Q1 | $1.27M | Sell |
41,012
-480
| -1% | -$14.8K | ﹤0.01% | 1176 |
|
|
2023
Q4 | $1.68M | Sell |
41,492
-700
| -2% | -$28.3K | 0.01% | 977 |
|
|
2023
Q3 | $1.11M | Sell |
42,192
-16,278
| -28% | -$429K | ﹤0.01% | 1046 |
|
|
2023
Q2 | $1.01M | Buy |
58,470
+9,268
| +19% | +$159K | ﹤0.01% | 1079 |
|
|
2023
Q1 | $815K | Buy |
49,202
+3,885
| +9% | +$64.4K | ﹤0.01% | 1148 |
|
|
2022
Q4 | $345K | Sell |
45,317
-5,046
| -10% | -$38.4K | ﹤0.01% | 1418 |
|
|
2022
Q3 | $500K | Sell |
50,363
-16,476
| -25% | -$164K | ﹤0.01% | 1268 |
|
|
2022
Q2 | $606K | Sell |
66,839
-23,449
| -26% | -$213K | ﹤0.01% | 1185 |
|
|
2022
Q1 | $915K | Sell |
90,288
-1,018,945
| -92% | -$10.3M | ﹤0.01% | 1085 |
|
|
2021
Q4 | $18.5M | Buy |
1,109,233
+272,319
| +33% | +$4.54M | 0.09% | 232 |
|
|
2021
Q3 | $39.2M | Buy |
836,914
+4,830
| +0.6% | +$226K | 0.21% | 119 |
|
|
2021
Q2 | $50.7M | Buy |
832,084
+12,452
| +2% | +$759K | 0.29% | 79 |
|
|
2021
Q1 | $50.5M | Buy |
819,632
+42,601
| +5% | +$2.62M | 0.34% | 66 |
|
|
2020
Q4 | $55.3M | Buy |
+777,031
| New | +$55.3M | 0.42% | 51 |
|